Phase 1 clinical trial

December 19, 2018December 19, 2018

Protagonist Therapeutics Starts Phase 1 Trial of Potential Ulcerative Colitis Treatment PN-10943

News

Protagonist Therapeutics has begun dosing patients in a Phase 1 clinical trial of an oral ulcerative colitis (UC) treatment candidate known as PN-10943, the company announced in a press release. PN-10943 is ... Read more

December 5, 2018December 5, 2018

Potential IBD Therapy PTG-200 Safe, Well-tolerated in Healthy Volunteers, Phase 1 Results Show

News

PTG-200, being developed by Protagonist Therapeutics in collaboration with Janssen Biotech for the treatment of moderate and severe Crohn’s disease, was found safe and well-tolerated in healthy volunteers, according to top-line results of ... Read more

December 22, 2017December 22, 2017

Ionis Brings Treatment for Gastrointestinal Immune Disorders to Clinical-trial Stage

News

Janssen Biotech plans a Phase 1 clinical trial of a therapy that its partner Ionis Pharmaceuticals developed as a treatment for gastrointestinal immune disorders. Under their collaboration agreement, Ionis received $5 million for bringing ... Read more